Empresa Sorrento Therapeutics, Inc.
Acciones
SRNEQ
US83587F2020
Biotecnología e investigación médica
Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
0,008 USD | 0,00 % | 0,00 % | -93,52 % |
Resumen de negocios
Número de empleados: 949
Ventas por actividad
USD en millones | 2021 | Peso | 2022 | Peso | Delta |
---|---|---|---|---|---|
Scilex
60,5
%
| 29 | 54,0 % | 38 | 60,5 % | +33,24 % |
Sorrento Therapeutics
39,5
%
| 24 | 46,0 % | 25 | 39,5 % | +1,84 % |
Ventas por región
USD en millones | 2021 | Peso | 2022 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 53 | 100,0 % | 63 | 100,0 % | +18,78 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Henry Ji
CEO | Chief Executive Officer | 59 | 01/01/89 |
Shawn Sahebi
COO | Chief Operating Officer | - | - |
Mike A. Royal
CTO | Chief Tech/Sci/R&D Officer | 70 | 03/03/14 |
Director/Board Member | 60 | 01/10/17 | |
Jaisim Shah
BRD | Director/Board Member | 63 | 11/09/13 |
Brian Cooley
IRC | Investor Relations Contact | - | - |
William Farley
SAM | Sales & Marketing | 68 | - |
Alexis Nahama
PRN | Corporate Officer/Principal | - | 01/02/17 |
General Counsel | - | 01/01/17 | |
Mohsin Meghji
PRN | Corporate Officer/Principal | 60 | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Kim D. Janda
BRD | Director/Board Member | 67 | 01/04/12 |
David Lemus
BRD | Director/Board Member | 61 | 01/10/17 |
Jaisim Shah
BRD | Director/Board Member | 63 | 11/09/13 |
Yue Wu
BRD | Director/Board Member | 60 | 01/08/16 |
Henry Ji
CEO | Chief Executive Officer | 59 | 01/01/89 |
Director/Board Member | 60 | 01/10/17 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 558 849 336 | 546 375 093 ( 97,77 %) | 7 568 182 ( 1,354 %) | 97,77 % |
Participaciones
Nombre | Acciones | % | Valoración |
---|---|---|---|
SCILEX HOLDING COMPANY 1.21% | 1 917 210 | 1.21% | 4 352 067 $ |
CELULARITY INC. 2.32% | 505 043 | 2.32% | 1 808 054 $ |
Información de la empresa
Sorrento Therapeutics, Inc.
4955 Directors Place
92121, San Diego
+858 203 4100
http://sorrentotherapeutics.comSector
Ventas por actividad
Varia. 1 de ene. | Capi. | |
---|---|---|
-93,52 % | 4,35 M | |
+2,73 % | 108 mil M | |
+9,59 % | 103 mil M | |
+6,58 % | 23,48 mil M | |
-12,59 % | 21,93 mil M | |
-3,29 % | 19,68 mil M | |
-35,36 % | 18,37 mil M | |
-13,29 % | 16,33 mil M | |
+4,68 % | 13,72 mil M | |
+34,25 % | 12,15 mil M |
- Bolsa
- Acciones
- Acción Sorrento Therapeutics, Inc. - OTC Markets
- Empresa Sorrento Therapeutics, Inc.